The FDA changes the rules — rare disease patients pay with their lives

The Food and Drug Administration just dealt a crushing setback to patients living with Duchenne muscular dystrophy. Last week, the FDA’s advisory...

12.08.2026 7

Washington Examiner

Tricia Flanagan